Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC

Name: Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC
License: Public Domain

Nuvation Bio Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

carcinoma lung-neoplasms neoplasms

lung neoplasms, respiratory tract neoplasms, thoracic neoplasms, neoplasms by site, neoplasms, lung diseases, respiratory tract diseases, carcinoma, bronchogenic carcinoma, non small cell carcinoma of the lung, ros1-positive non-small cell lung cancer (nsclc), non-small cell lung cancer (nsclc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 872414
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.